ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,061.71
0.50%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Karolinska Development Ab (0P3C)

  7. Karolinska Development Ab (0P3C) News

Karolinska Development Ab (0P3C)

Karolinska Development Ab
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0P3C
DateTimeSourceHeadlineSymbolCompany
28/05/202407:00UK RegulatoryKarolinska Development invests in BOOST Pharma, expanding its portfolioLSE:0P3CKarolinska Development Ab
16/05/202415:40UK RegulatoryKarolinska Development’s Annual General Meeting 2024LSE:0P3CKarolinska Development Ab
08/05/202408:30UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBCLSE:0P3CKarolinska Development Ab
26/04/202407:00UK RegulatoryInterim Report - January-March 2024LSE:0P3CKarolinska Development Ab
16/04/202407:00UK RegulatoryNotice of Annual General Meeting in Karolinska Development AB (publ)LSE:0P3CKarolinska Development Ab
22/03/202408:30UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBCLSE:0P3CKarolinska Development Ab
22/03/202407:00UK RegulatoryKarolinska Development Annual Report 2023 publishedLSE:0P3CKarolinska Development Ab
14/03/202411:48UK RegulatoryKarolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 millionLSE:0P3CKarolinska Development Ab
14/03/202410:24UK RegulatoryKarolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of unitsLSE:0P3CKarolinska Development Ab
06/03/202408:00UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PDLSE:0P3CKarolinska Development Ab
16/02/202407:00UK RegulatoryYear-end Report - January-December 2023LSE:0P3CKarolinska Development Ab
 Showing the most relevant articles for your search:LSE:0P3C

Your Recent History

NASDAQ
MMJCX
MassMutual Clinton Munic...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved